Washington, DC, United States of America

Andrea Lisco

This inventor holds 1 USPTO granted patent. Top assignees: Katholieke Universiteit Leuven, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrea Lisco: Innovator in Viral Infection Treatment

Introduction

Andrea Lisco is a prominent inventor based in Washington, DC, who has made significant contributions to the field of viral infection treatment. With a focus on innovative compounds and methods, she has developed solutions aimed at combating viral infections, including HIV.

Latest Patents

Andrea Lisco holds a patent for "Compounds and methods for the treatment of viral infection." This invention relates to the use of monophosphorylated prodrugs of acyclovir or its derivatives to treat or prevent viral infections. Her work is particularly relevant for individuals suffering from or susceptible to viral infections.

Career Highlights

Throughout her career, Andrea has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Katholieke Universiteit Leuven. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Andrea has collaborated with notable colleagues, including Leonid Margolis and Jan Balzarini. These partnerships have enriched her research and expanded the impact of her work in the field of viral infections.

Conclusion

Andrea Lisco's innovative approach to treating viral infections showcases her dedication to advancing medical science. Her contributions are vital in the ongoing fight against viral diseases, and her work continues to inspire future research in this critical area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…